Authors
Kari AO Tikkinen, Philipp Dahm, Lyubov Lytvyn, Anja F Heen, Robin WM Vernooij, Reed AC Siemieniuk, Russell Wheeler, Bill Vaughan, Awah Cletus Fobuzi, Marco H Blanker, Noelle Junod, Johanna Sommer, Jérôme Stirnemann, Manabu Yoshimura, Reto Auer, Helen MacDonald, Gordon Guyatt, Per Olav Vandvik, Thomas Agoritsas
Publication date
2018/9/5
Journal
Bmj
Volume
362
Publisher
British Medical Journal Publishing Group
Description
There is considerable variability among men's values and preferences regarding prostate cancer screening. Men who place a high value in avoiding complications from biopsies and subsequent treatment are likely to decline screening. In contrast, men who place a higher value in even a small reduction of prostate cancer mortality may opt for screening. Higher risk patients may be more likely to seek screening because they may worry more about prostate cancer and want to rule out the diagnosis.
Scholar articles
KAO Tikkinen, P Dahm, L Lytvyn, AF Heen… - Bmj, 2018